Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zinc aspartate is a chelated zinc supplement, a salt formed from zinc and the amino acid aspartic acid. It is typically a white crystalline powder. This form of zinc is favored for its enhanced bioavailability and absorption due to the chelation with aspartate. It is widely used to treat and prevent zinc deficiencies, which can impact numerous bodily functions. Zinc aspartate plays a crucial role in over 300 enzymatic processes, DNA and protein synthesis, cell growth, and wound healing. It also exhibits immunomodulatory, antioxidant, anti-inflammatory, and antimicrobial properties. Studies have explored its potential in stimulating immune responses, such as tetanus antibody formation and T lymphocyte activation, particularly in zinc-deficient individuals like chronic hemodialysis patients. Additionally, it has been investigated for its therapeutic potential in conditions like obesity, inflammatory bowel disease, osteoporosis, and rheumatoid arthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zinc aspartate.